Pain Therapeutics, Inc. (NASDAQ:PTIE)

CAPS Rating: 2 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Recs

0
Player Avatar pchop123 (79.69) Submitted: 2/5/2013 8:53:37 PM : Outperform Start Price: $2.88 PTIE Score: -5.58

Upside cometh sooneth

Featured Broker Partners


Advertisement